首页> Immunology> Adaptive immunity programmes in breast cancer.

Adaptive immunity programmes in breast cancer.

导出 OA

翻译打印收藏纠错

第一作者： Frederick S,Varn

第一单位： Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.

作者： Frederick S,Varn ^[1] ; David W,Mullins ^[2] ; Hugo,Arias-Pulido ^[3] ; Steven,Fiering ^[4] ; Chao,Cheng ^[5]

作者单位： Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA. ^[1] Department of Medical Education, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.;Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.;Norris Cotton Cancer Center, Lebanon, NH, USA. ^[2] Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. ^[3] Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.;Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.;Norris Cotton Cancer Center, Lebanon, NH, USA. ^[4] Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.;Norris Cotton Cancer Center, Lebanon, NH, USA.;Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. ^[5]

关键词 T cells adaptive immunity breast cancer immunotherapy neoantigens

医学主题词适应性免疫(Adaptive Immunity);动物(Animals);乳腺肿瘤(Breast Neoplasms);女(雌)性(Female);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);T淋巴细胞(T-Lymphocytes)

DOI 10.1111/imm.12664

PMID 27564847

发布时间 2025-01-05

基金项目

KL2 TR001088/TR/NCATS NIH HHS/United States T32 GM008704/GM/NIGMS NIH HHS/United States UL1 TR001086/TR/NCATS NIH HHS/United States

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交